Cameron R. Nelson
Directeur Financier/CFO chez Mati Therapeutics, Inc.
Postes actifs de Cameron R. Nelson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Mati Therapeutics, Inc.
 Mati Therapeutics, Inc. BiotechnologyHealth Technology Mati Therapeutics, Inc. operates as biotechnology company. It develops non-invasive sustained drug delivery platform to treat ocular diseases, in particular glaucoma. The company was founded by Robert Lee Butchofsky and Christopher A. Muller and is headquartered in Austin, TX. | Directeur Financier/CFO | - | - |
Historique de carrière de Cameron R. Nelson
Anciens postes connus de Cameron R. Nelson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Comptroller/Controller/Auditor | 24/05/2010 | 30/11/2011 |
| Directeur Financier/CFO | 01/05/2000 | 09/07/2012 |
Formation de Cameron R. Nelson
| Dartmouth College | Masters Business Admin |
| University of British Columbia | Undergraduate Degree |
Statistiques
Internationale
| Canada | 3 |
| Etats-Unis | 3 |
Opérationnelle
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
| Masters Business Admin | 1 |
Sectorielle
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Mati Therapeutics, Inc.
Mati Therapeutics, Inc. BiotechnologyHealth Technology Mati Therapeutics, Inc. operates as biotechnology company. It develops non-invasive sustained drug delivery platform to treat ocular diseases, in particular glaucoma. The company was founded by Robert Lee Butchofsky and Christopher A. Muller and is headquartered in Austin, TX. | Health Technology |
- Bourse
- Insiders
- Cameron R. Nelson
- Expérience
